| 000 | 00941 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250512050451.0 | ||
| 264 | 0 | _c19880526 | |
| 008 | 198805s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/80.5.301 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWittes, R E | |
| 245 | 0 | 0 |
_aNoninvestigational uses of investigational drugs: some implications of FDA's revised regulations. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cMay 1988 |
||
| 300 |
_a301-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLegislation, Drug |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 80 _gno. 5 _gp. 301-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/80.5.301 _zAvailable from publisher's website |
| 999 |
_c3362947 _d3362947 |
||